CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation

Abstract

Hypercholesterolemia is associated with phenotypic changes in endothelial cell function that lead to a proinflammatory and prothrombogenic state in different segments of the microvasculature. CD40 ligand (CD40L) and its receptor CD40 are ubiquitously expressed and mediate inflammatory responses and platelet activation. The objective of this study was to determine whether CD40/CD40L, in particular T-cell CD40L, contributes to microvascular dysfunction induced by hypercholesterolemia. Intravital microscopy was used to quantify blood cell adhesion in cremasteric postcapillary venules, endothelium-dependent vasodilation responses in arterioles, and microvascular oxidative stress in wild-type (WT) C57BL/6, CD40-deficient ((-/-)), CD40L(-/-), or severe combined immune deficient (SCID) mice placed on a normal (ND) or high-cholesterol (HC) diet for 2 wk. WT-HC mice exhibited an exaggerated leukocyte and platelet recruitment in venules and impaired vasodilation responses in arterioles compared with ND counterparts. A deficiency of CD40, CD40L, or lymphocytes attenuated these responses to HC. The HC phenotype was rescued in CD40L(-/-) and SCID mice by a transfer of WT T cells. Bone marrow chimeras revealed roles for both vascular- and blood cell-derived CD40 and CD40L in the HC-induced vascular responses. Hypercholesterolemia induced an oxidative stress in both arterioles and venules of WT mice, which was abrogated by either CD40 or CD40L deficiency. The transfer of WT T cells into CD40L(-/-) mice restored the oxidative stress. These results implicate CD40/CD40L interactions between circulating cells and the vascular wall in both the arteriolar and venular dysfunction elicited by hypercholesterolemia and identify T-cell-associated CD40L as a key mediator of these responses.

New Markers of Early Cardiovascular Risk in Multiple Sclerosis Patients: Oxidized-LDL Correlates with Clinical Staging

“…Under normal and physiological conditions, high concentrations of HDL and LDL are present in CNS, as a result of transport across the brain-blood barrier (BBB) [21]. However, dyslipidemia can potentiate inflammatory processes at the vascular endothelium, lead to the production of adhesion molecules and to the recruitment of leukocytes [22,23]. The recruitment and extravasation of immune cells across the activated endothelium of the BBB is considered to be a critical step in MS pathogenesis.…”

Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis

“…The most dramatic negative effect is on the promotion of splenocyte adhesion, which is known to contribute to inflammation and plaque growth (31). The endothelial function was also impaired by late catechin treatment, as revealed by the reduction in vascular sensitivity to ACh.…”

“…With age, risk factors for cardiovascular diseases (CVD) such as hypercholesterolemia accelerate endothelial damages, leading to inflammation and an excess production of reactive oxygen species (ROS) (9). The known consequences are an increased adhesiveness of the leukocytes onto the endothelium (31) and a reduced vasodilatory function accompanied by an augmented vascular production of vaso-constricting factors (14). All these changes point to a reduction in antioxidant defenses that yield to the development of atherosclerotic lesions (38,39).…”

Hypercholesterolemia and Risk of Incident Psoriasis and Psoriatic Arthritis in US Women

“…However, the causal relationship between hypercholesterolemia and psoriasis/PsA is unclear. Hypercholesterolemia is able to induce microvascular inflammation with the involvement of immune system (18), and T lymphocytes may be one of the early cell types activated by hypercholesterolemia (19). Interestingly, psoriasis is characterized by T-cell-mediated hyperproliferation of keratinocytes and inflammatory processes (20), and is classified as a T helper 1 (Th1) disease (21).…”